ELIZABETH SHPALL to Filgrastim
This is a "connection" page, showing publications ELIZABETH SHPALL has written about Filgrastim.
Connection Strength
0.183
-
The utilization of cytokines in stem cell mobilization strategies. Bone Marrow Transplant. 1999 May; 23 Suppl 2:S13-9.
Score: 0.041
-
A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients. Blood. 1999 Apr 15; 93(8):2491-501.
Score: 0.041
-
High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation. Transplantation. 2009 Oct 27; 88(8):1019-24.
Score: 0.021
-
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma. Biol Blood Marrow Transplant. 2009 Jun; 15(6):718-23.
Score: 0.020
-
Phase I trial of parathyroid hormone to facilitate stem cell mobilization. Biol Blood Marrow Transplant. 2007 Jul; 13(7):838-43.
Score: 0.018
-
Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma. Br J Haematol. 2006 Jun; 133(5):533-7.
Score: 0.017
-
High-dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast cancer in patients with 4-9 involved axillary lymph nodes. Bone Marrow Transplant. 1997 Dec; 20(11):931-7.
Score: 0.009
-
Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients. Blood. 1997 Oct 15; 90(8):2939-51.
Score: 0.009
-
Clinical applications of filgrastim and stem cell factor in vivo and in vitro. J Hematother. 1994; 3(4):353-5.
Score: 0.007